Sign in

CIK 0001534969 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
261911522
Phone
(801) 990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
  1. 4 Open-market sale Chief Medical Officer sold 362 shares at $2.01 ($728)
  2. 4 Open-market sale General Counsel sold 2,179 shares at $2.01 ($4,380)
  3. 4 Open-market sale Chief Executive Officer sold 20,755 shares at $2.08 ($43,170)
  4. 4 Open-market sale Chief Financial Officer sold 5,440 shares at $2.08 ($11,315)
  5. 4 Planned sale Director sold 1,560 shares at $2.15 ($3,354)
  6. 4 Insider Changes in Ownership
  7. 4 Grant or award General Counsel acquired 5,000 shares (grant or award)
  8. 4 Grant or award Chief Commercial Officer acquired 3,168 shares (grant or award)
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Grant or award Chief Executive Officer acquired 154,440 shares (grant or award)
  13. 4 Grant or award General Counsel acquired 44,215 shares (grant or award)
  14. 4 Grant or award Chief Medical Officer acquired 17,437 shares (grant or award)
  15. 4 Grant or award Chief Commercial Officer acquired 12,455 shares (grant or award)
  16. 4 Grant or award Chief Financial Officer acquired 44,215 shares (grant or award)
  17. 4 Open-market sale Chief Executive Officer sold 25,612 shares at an average $1.92 ($49,079)
  18. 4 Open-market sale Chief Data Officer sold 1,396 shares at $2.04 ($2,848)
  19. 4 Open-market sale General Counsel sold 1,027 shares at $2.04 ($2,095)
  20. 4 Open-market sale Chief Information Officer sold 716 shares at $2.04 ($1,461)

Page 2 of 16 · 313 filings